Too hard to say for ASX200, probably not this round as most are well above $700 million mcap. ASX 300 definitely.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025